Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 26 Feb 2021 08:00 CET |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | 20103010 Biotechnology | Other subject |
| 26 Feb 2021 08:00 CET |
ACACIA PHARMA | Transparency Notification | 20103010 Biotechnology | Other subject |
| 23 Feb 2021 08:00 CET |
ACACIA PHARMA | Admission to Trading on Euronext Brussels | 20103010 Biotechnology | Other subject |
| 19 Feb 2021 08:00 CET |
ACACIA PHARMA | Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities | 20103010 Biotechnology | Other subject |
| 18 Feb 2021 13:15 CET |
ACACIA PHARMA | Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS® | 20103010 Biotechnology | Other subject |
| 18 Feb 2021 09:00 CET |
ACACIA PHARMA | Change of EU home Member State | 20103010 Biotechnology | Other subject |
| 12 Feb 2021 07:00 CET |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | 20103010 Biotechnology | Other subject |
| 04 Feb 2021 07:00 CET |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | 20103010 Biotechnology | Other subject |
| 28 Jan 2021 07:00 CET |
ACACIA PHARMA | Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less | 20103010 Biotechnology | Other subject |
| 21 Jan 2021 13:00 CET |
ACACIA PHARMA | Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference | 20103010 Biotechnology | Other subject |
| 20 Jan 2021 11:40 CET |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | 20103010 Biotechnology | Other subject |
| 20 Jan 2021 08:00 CET |
ACACIA PHARMA | Acacia Pharma wins BEL Small Company of the Year for the second consecutive year | 20103010 Biotechnology | Other subject |
| 18 Dec 2020 13:45 CET |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 18 Dec 2020 13:18 CET |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 18 Dec 2020 13:17 CET |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 18 Dec 2020 11:04 CET |
ACACIA PHARMA | Admission to Trading on Euronext Brussels | 20103010 Biotechnology | Other subject |
| 17 Dec 2020 11:14 CET |
ACACIA PHARMA | Publication of Supplementary Prospectus | 20103010 Biotechnology | Other subject |
| 15 Dec 2020 09:07 CET |
ACACIA PHARMA | Correction: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ | 20103010 Biotechnology | Other subject |
| 15 Dec 2020 07:46 CET |
ACACIA PHARMA | Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ | 20103010 Biotechnology | Other subject |
| 13 Oct 2020 09:12 CEST |
ACACIA PHARMA | Director/PDMR Shareholding | 20103010 Biotechnology | Other subject |
| 13 Oct 2020 09:10 CEST |
ACACIA PHARMA | Director/PDMR Shareholding | 20103010 Biotechnology | Other subject |
| 13 Oct 2020 09:06 CEST |
ACACIA PHARMA | Issue of Shares to Employee Benefit Trust | 20103010 Biotechnology | Other subject |
| 09 Oct 2020 07:00 CEST |
ACACIA PHARMA | Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ | 20103010 Biotechnology | Other subject |
| 06 Oct 2020 16:45 CEST |
ACACIA PHARMA | Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US | 20103010 Biotechnology | Other subject |
| 24 Aug 2020 07:00 CEST |
ACACIA PHARMA | BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV | 20103010 Biotechnology | Other subject |
| 19 Aug 2020 12:16 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 19 Aug 2020 12:14 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 19 Aug 2020 12:10 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 18 Aug 2020 08:01 CEST |
ACACIA PHARMA | Admission to Trading on Euronext Brussels | 20103010 Biotechnology | Other subject |
| 14 Aug 2020 13:25 CEST |
ACACIA PHARMA | Publication of Prospectus | 20103010 Biotechnology | Other subject |
| 14 Aug 2020 08:00 CEST |
ACACIA PHARMA | Results of Placing | 20103010 Biotechnology | Other financial transaction |
| 13 Aug 2020 15:01 CEST |
ACACIA PHARMA | Proposed Capital Raising by way of a Placing of New Ordinary Shares | 20103010 Biotechnology | Other financial transaction |
| 13 Aug 2020 15:00 CEST |
ACACIA PHARMA | Interim Results for the Six Months ended 30 June 2020 | 20103010 Biotechnology | Other subject |
| 27 Jul 2020 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® | 20103010 Biotechnology | Other subject |
| 21 Jul 2020 12:43 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 21 Jul 2020 12:38 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 21 Jul 2020 12:34 CEST |
ACACIA PHARMA | Holding(s) in Company | 20103010 Biotechnology | Other subject |
| 16 Jul 2020 13:48 CEST |
ACACIA PHARMA | Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies | 20103010 Biotechnology | Other subject |
| 15 Jul 2020 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV | 20103010 Biotechnology | Other subject |
| 02 Jul 2020 20:02 CEST |
ACACIA PHARMA | Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedatio | 20103010 Biotechnology | Other subject |
| 08 Jun 2020 11:01 CEST |
ACACIA PHARMA | TR-1: Standard form for notification of major holdings | 20103010 Biotechnology | Other subject |
| 04 Jun 2020 11:03 CEST |
ACACIA PHARMA | TR-1: Standard form for notification of major holdings | 20103010 Biotechnology | Other subject |
| 04 Jun 2020 10:59 CEST |
ACACIA PHARMA | TR-1: Standard form for notification of major holdings | 20103010 Biotechnology | Other subject |
| 01 Jun 2020 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals | 20103010 Biotechnology | Other subject |
| 08 May 2020 07:00 CEST |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | Pharmaceuticals | Other subject |
| 07 May 2020 07:00 CEST |
ACACIA PHARMA | Issue of Equity on Exercise of Options/Vesting of Performance Share Awards | Pharmaceuticals | Other subject |
| 07 Apr 2020 23:19 CEST |
ACACIA PHARMA | Alessandro Della Chà appointed as Director of Acacia Pharma Group plc | Pharmaceuticals | Other subject |
| 07 Apr 2020 23:15 CEST |
ACACIA PHARMA | Results of Annual General Meeting | Pharmaceuticals | Other subject |
| 24 Mar 2020 18:36 CET |
ACACIA PHARMA | Publication of Prospectus | Pharmaceuticals | Other subject |
| 23 Mar 2020 10:00 CET |
ACACIA PHARMA | Forthcoming 2020 Annual General Meeting – Change of Venue and Proxy Forms | Pharmaceuticals | Other subject |